Symptoms of anxiety and depression often appear together in patients,
either as 2 discrete disorders, such as major depressive disorder and
panic disorder, or as a combination of symptoms not meeting criteria f
or specific disorders. The social, economic, occupational and medical
costs of such comorbid anxiety and depression can be enormous, affecti
ng both the individual and society, The clinician must be creative whe
n treating patients with mixed anxiety and depressive symptoms; psycho
pharmacological treatment can involve the use of a variety of mono-and
polytherapies. Benzodiazepines can be effective in treating anxiety s
ymptoms, but unwanted adverse effects limit their use to the short ter
m. Tricyclic antidepressants, although proven to be effective in treat
ing both anxiety and depressive symptoms, have numerous adverse effect
s, making them a second-choice therapy. Traditional monoamine oxidase
inhibitors have proven efficacy in atypical depression, and the newer
reversible and selective inhibitors of monoamine oxidase-A may prove t
o be very effective in treating both sets of symptoms. Of particular i
mportance in the treatment of patients with anxiety and depressive sym
ptoms are the selective serotonin (5-hydroxytryptamine; 5-MT) reuptake
inhibitors, nefazodone and the azapirones (including buspirone).